Clinical Trials Directory

Trials / Completed

CompletedNCT03186820

Exploratory Study of the Interest of MRI Susceptibility Weighted Imaging for the Pre-operative Assessment of Pelvic Endometriosis Extent

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Knowledge of the precise location of endometriosis is essential for a successful surgical treatment. MRI Susceptibility-Weighted Imaging (SWI-MRI) yields high sensitivity for blood by-products detection. Since endometriosis lesions are haemorrhagic, and therefore rich in blood by-products such as hemosiderin, SWI-MRI could be useful in the pre-operative assessment of endometriosis, especially in superficial peritoneal lesion detection. The purpose of our study is to evaluate the performance of SWI-MRI for the preoperative work-up of endometriosis

Detailed description

Pelvic endometriosis is a cause of pelvic pain, dysmenorrhea, urinary symptoms and infertility. MRI is considered as the best imaging technique to detect and to predict the extent of the disease. Susceptibility Weighted Imaging is routinely performed to identify haemorrhagic lesions in brain MRI protocols and has proven to be a sensitive technique to detect blood by-products. A pelvic MRI protocol including SWI will be performed in all women addressed for diagnostic assessment or pre-operative work-up of endometriosis.

Conditions

Interventions

TypeNameDescription
OTHERSusceptibility Weighted Imaging as 3D SWAN sequenceSusceptibility Weighted Imaging as 3D SWAN sequence

Timeline

Start date
2017-06-19
Primary completion
2018-04-24
Completion
2018-04-24
First posted
2017-06-14
Last updated
2018-11-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03186820. Inclusion in this directory is not an endorsement.